New ways to use telehealth for finding and managing glaucoma and other serious eye conditions in people at higher risk
DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations
This project explores if using telemedicine can help find glaucoma and other serious eye problems earlier in Black and Latino individuals and those with limited access to eye care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11174193 on NIH RePORTER |
What this research studies
Many people with glaucoma don't know they have it until it's advanced, especially in communities with less access to eye doctors. This project will test a new way to screen for glaucoma using telemedicine, which means you might get your eyes checked remotely. We want to see if this approach is good at finding glaucoma and other issues like cataracts or vision problems. The goal is to make eye care more accessible and help people get treatment sooner.
Who could benefit from this research
Good fit: Ideal candidates for this project are Black and Latino individuals, or those who receive care at Federally Qualified Health Centers in northern California, who may be at higher risk for glaucoma.
Not a fit: Patients who are not in the identified high-risk groups or who do not live in the specified geographic area may not directly benefit from this particular screening program.
Why it matters
Potential benefit: If successful, this project could lead to earlier detection and better management of glaucoma and other eye diseases, potentially preventing vision loss for many.
How similar studies have performed: While general population screening for eye disease is not widely recommended, this project explores a novel telemedicine-based approach specifically for high-risk groups, which is being tested for its effectiveness and cost-efficiency.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Keenan, Jeremy David — University of California, San Francisco
- Study coordinator: Keenan, Jeremy David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.